Hellow guys, Welcome to my website, and you are watching GI Cancer ASCO 2023 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Muhammad Shaalan Beg. and this vIdeo is uploaded by OncBrothers: Practice-Changing Cancer Discussions at 2023-06-29T10:40:25-07:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | GI Cancer ASCO 2023 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Muhammad Shaalan Beg |
| Video Uploader | Video From OncBrothers: Practice-Changing Cancer Discussions |
| Upload Date | This Video Uploaded At 29-06-2023 17:40:25 |
| Video Discription | Discussing GI (Gastrointestinal) Cancer ASCO 2023 Highlights, focusing on practice changing studies with Dr. Muhammad Shaalan Beg, Co-Leader Gastrointestinal Oncology, Adjunct Associate Professor of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center. Covering three important studies: - PROSPECT: ph III trial of neoad chemoRT vs neoadj FOLFOX chemo with selective use of chemoRT, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) - NORPACT-1: Short-course neoadj FOLFIRINOX vs upfront surgery for resectable pancreatic head cancer - NAPOLI 3: ph III trial in mets pancreatic ductal adenocarcinoma pts, liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) vs nab-paclitaxel + gemcitabine - IMbrave050: Efficacy, safety and patient reported outcomes (PROs) from the phase III IMbrave050 trial of adj atezo + bev vs active surveillance in pts with HCC #oncbrothers #2023 #asco #Gastrointestinal #cancer Website: http://www.oncbrothers.com/ Twitter: https://twitter.com/oncbrothers Contact us at [email protected] |
| Category | People & Blogs |
| Tags | cancer | oncology | chemotherapy | therapy | guidelines | nccn | summary | OncBrothers | brothers | Highlights | Onc | rohit | gosain | rahul | video | abtract | society | american | onc | dr | doctor | dr. | healthcare | medicine | medical | oncbrothers | practice | changing | malignancy | malignant | chemo | treatment | prognosis | clinic | stage | tdxd | fda | approval | community | oncologist | oncoligists | chief | hamilton | rugo | center | professor | associate | ct | 2023 | asco | esmo | pembrolizumab | beg | shaalan | pashtoon | imbrave | norpact | napoli | folifirnox | folfox | surgery | neodjuvant | texas |
